Are You Keeping Tabs on What Management Is Doing With Your Money?

Find out what you can do to keep yourself from staying up at night wondering about what companies like Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are doing with your hard-earned money.

| More on:

The idea behind making an investment in the equity of a publicly traded company is that you’re essentially handing over your hard-earned capital to the company’s managers, who you are expecting to earn you a fair return on your investment.

But how sure are you that’s what’s happening with the investments you currently own?

Understanding the shareholder-manager agency problem

The shareholder-manager agency problem is a problem that is about as old as capitalism itself.

The problem arises because the shareholders — that would be you as an investor, or the owner of a company — are the one providing the capital, or money, to pay the bills, hire staff, and invest in capital expenses like plants and equipment.

Yet it’s actually not you, but rather the employees, or management, of the company who are actually the ones responsible for making the hiring, firing and investment decisions on a day-to-day basis.

That means it’s up to the owners — and not the senior managers — of the company to ensure that management is making responsible decisions with the profits of the firm.

Let’s take a closer look at the options available to management as to what they are able to do with a firm’s capital and how those decisions can impact shareholder wealth.

Mergers and acquisitions

This is potentially the avenue most fraught with disastrous outcomes. That’s because sometimes managers of a company find themselves incentive to pursue merger and acquisition (M&A) opportunities to meet certain financial targets.

But the problem arises when those managers place undue emphasis on short-term financial incentives, like year-end bonuses, at the expense of more positive long-term shareholder outcomes.

That type of scenario can lead to disastrous investment outcomes. Look no further than the fate that befell Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) as but one recent example of an M&A strategy gone wrong.

Retiring debt obligations

Management can use a firm’s profits to retire outstanding debt obligations; sometimes it makes sense, and in other cases, not so much.

If, on the one hand, your firm (for example, the aforementioned Valeant Pharmaceuticals) has racked up an unsustainable balance of debt, paying down those financial obligations can be the responsible thing to do.

On the other hand, it may raise questions as to how management got themselves in that position in the first place.

In most cases, firms will target what is referred to as an optimal capital structure — or the optimal mix of debt in relation to assets and equity. Allocating capital in this manner can be an indication that management is, in fact, creating shareholder wealth by adding to or subtracting from its liabilities.

Returning profits to shareholders through dividends and buybacks

Paying a healthy and growing dividend has to be the most tried and true — and probably most “fail-safe” — approach to dealing with shareholders’ money in a responsible and sustainable manner.

Returning firm profits via either dividends or buybacks ensures that shareholders have a say on where the money will be directed — either through reinvestment in the firm or otherwise.

Bottom line

The best thing that investors can do for themselves to help mitigate the risk of the shareholder-manager agency problem is to only invest in companies with demonstrable track records of creating shareholder wealth.

Following that simple rule of thumb will help keep you from staying awake at night wondering what those strangers are doing with your money.

Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jason Phillips has no position in any of the stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Dividend Stocks

money while you sleep
Dividend Stocks

Buy These 3 High-Yield Dividend Stocks Today and Sleep Soundly for a Decade

High-yield stocks like Enbridge have secular trends on their side, as well as predictable cash flows and a lower interest…

Read more »

stock research, analyze data
Dividend Stocks

Invest $9,000 in This Dividend Stock for $59.21 in Monthly Passive Income

Monthly passive income can be an excellent way to easily increase your over income over time. And here is a…

Read more »

Man holds Canadian dollars in differing amounts
Dividend Stocks

Invest $8,000 in This Dividend Stock for $320.40 in Passive Income

This dividend stock remains a top choice for investors wanting to bring in passive income for life, and even only…

Read more »

monthly desk calendar
Dividend Stocks

Monthly Dividend Leaders: 3 TSX Stocks Paying Dividends Every 30 Days

These monthly dividend stocks offer a high yield of over 7% and have durable payouts.

Read more »

space ship model takes off
Dividend Stocks

2 Stocks I’d Avoid in 2025 (and 1 I’d Buy)

Two low-priced stocks are best avoided for now but a surging oil bellwether is a must-buy.

Read more »

Paper Canadian currency of various denominations
Dividend Stocks

Want 6% Yield? 3 TSX Stocks to Buy Today

These TSX dividend stocks have sustainable payouts and are offering high yields of 6% near their current price levels.

Read more »

A woman shops in a grocery store while pushing a stroller with a child
Dividend Stocks

Is Metro Stock a Buy for its 1.5% Dividend Yield?

Metro is a defensive stock that's a reasonable buy here for a long-term investment.

Read more »

Man data analyze
Dividend Stocks

This 7.2% Dividend Stock Pays Cash Every Single Month

This top dividend stock is offering massive dividends, but are they safe? Let's dig in today.

Read more »